Subtype
Lung Carcinoma
CI-CAN-00001086Explore in graph →
2,130 active trials51 approved drugs598 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001086Explore in graph →
Clinical trials
7,791 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,177)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00883675 | Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer | completed | Phase 4 | 133 | Michael MannNETWORK | 2 | Dec 18, 2013 | clinicaltrials |
| NCT00762346 | Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis | completed | Phase 4 | 156 | Sun Yat-sen UniversityOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00765687 |
| Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates(BLEST) |
| completed |
| Phase 4 |
| 432 |
| Sun Yat-sen UniversityOTHER |
| 1 |
| Dec 10, 2013 |
| clinicaltrials |
| NCT00536107 | Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 4 | 14 | AstraZenecaINDUSTRY | 1 | Oct 1, 2013 | clinicaltrials |
| NCT01020786 | A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients | completed | Phase 4 | 109 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 27, 2013 | clinicaltrials |
| NCT00829322 | Modafinil for the Treatment of Fatigue in Lung Cancer V9.0 | completed | Phase 4 | 208 | University of OxfordOTHER | 1 | Aug 19, 2013 | clinicaltrials |
| NCT00608868 | SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients(SELINE) | completed | Phase 4 | 156 | AstraZenecaINDUSTRY | 1 | Sep 28, 2012 | clinicaltrials |
| NCT01442909 | Pemetrexed Followed by Docetaxel or in Reverse Sequence | completed | Phase 4 | 44 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 29, 2011 | clinicaltrials |
| NCT00686322 | Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) | completed | Phase 4 | 6 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 15, 2011 | clinicaltrials |
| NCT01336192 | Maintenance Gemcitabine in the Chinese Advanced Lung Cancer(MAGICAL) | unknown | Phase 4 | 240 | Tongji UniversityOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT00380718 | Chemotherapy for Patients With Non-Small Cell Lung Cancer | completed | Phase 4 | 33 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 16, 2010 | clinicaltrials |
| NCT01211002 | Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) | unknown | Phase 4 | 170 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Sep 29, 2010 | clinicaltrials |
| NCT01000740 | A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa | completed | Phase 4 | 59 | AstraZenecaINDUSTRY | 1 | May 21, 2010 | clinicaltrials |
| NCT00813332 | Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC) | unknown | Phase 4 | 300 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Jan 25, 2010 | clinicaltrials |
| NCT01028729 | A Study of Endostar Combined With Chemotherapy Followed by Endostar Maintenance Therapy to Treat Advanced Non-small Cell Lung Cancer (NSCLC)(NSCLC) | unknown | Phase 4 | 120 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Dec 9, 2009 | clinicaltrials |
| NCT00099541 | Non-small Cell Lung Cancer Registry | completed | Phase 4 | 300 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00115206 | Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy | completed | Phase 4 | — | AmgenINDUSTRY | 0 | Apr 6, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Dec 18, 2013source: clinicaltrials